{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:43Z","timestamp":1792834723921,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Gehua Hugan Gao (GHHGG) is a traditional Chinese medicine paste that is chiefly used to treat liver cancer. However, the potential impact of GHHGG on liver cancer remains unclear. We explored how GHHGG treats liver cancer using bioinformatics, network pharmacology, and molecular docking. Network pharmacology included GHHGG active ingredients, predicted targets, predicted targets for liver cancer, and differential gene collection. A protein-protein interaction network was constructed using the Search Tool for the Retrieval of Interacting Genes\/Proteins database, and crucial targets were ranked according to their degree values. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of liver cancer targets were followed by survival, differential analysis, and molecular docking. Venn diagrams show 123 predicted GHHGG targets for the treatment of hepatocellular carcinoma (HCC). Enrichment analysis showed that GHHGG treats HCC through multiple targets and pathways. We also found that estrogen receptor 1, cytochrome P450 3A4, cyclin-dependent kinase 4, type IIA topoisomerase, aurora kinase A, and cyclin E1 targets were closely associated with HCC development through survival and differential analyses. Molecular docking confirmed GHHGG\u2019s strong affinity for liver cancer targets. This study helps us understand GHHGG ingredients and targets for liver cancer treatment. To a certain extent, the molecular mechanism of GHHGG in the treatment of liver cancer has been elucidated, thus providing a theoretical basis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050231","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:38Z","timestamp":1787968838000},"page":"e50231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the treatment of liver cancer with Gehua Hugan Gao based on bioinformatics, network pharmacology, and molecular docking"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0567-4678","authenticated-orcid":false,"given":"Guangze","family":"Ye","sequence":"first","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"},{"name":"Guizhou Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Yang","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"},{"name":"First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Chen","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Yan","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Qiu","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxi","family":"Long","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China"},{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"},{"name":"First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8114-1924","authenticated-orcid":false,"given":"Dongxin","family":"Tang","sequence":"additional","affiliation":[{"name":"Medical Translational Engineering Research Center for Prevention and Treatment of Oncology of Traditional Chinese Medicine and Ethnomedicine in Higher Education Institutions, Guiyang, Guizhou, China"},{"name":"TCM Tumor Inheritance and Scientific and Technological Innovation Talent Base of Guizhou, Guiyang, Guizhou, China"},{"name":"First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040.","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma.","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"889799","DOI":"10.3389\/fphar.2022.889799","article-title":"Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges.","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fphar.2020.00809","article-title":"Gehua Jiecheng Decoction inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice by improving tumor immunosuppression microenvironment.","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Pharmacol"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula.","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/ijms24043594","article-title":"Unraveling the role of Scutellaria baicalensis for the treatment of breast cancer using network pharmacology, molecular docking, and molecular dynamics simulation.","volume":"24","author":"Jiao","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"1235575","DOI":"10.3389\/fimmu.2023.1235575","article-title":"Mechanism of Bazhen Decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1080\/07391102.2023.2262587","article-title":"Integrating network pharmacology with molecular docking for elucidation of molecular biological mechanisms of Jiedu Qingjin formula for non-small cell lung cancer.","volume":"42","author":"Xu","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"115876","DOI":"10.1016\/j.jep.2022.115876","article-title":"Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.","volume":"302","author":"Shang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"D1404","DOI":"10.1093\/nar\/gkae1037","article-title":"HERB 2.0: an updated database integrating clinical and experimental evidence for traditional Chinese medicine.","volume":"53","author":"Fang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing.","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1109\/TCBB.2018.2874238","article-title":"Identifying key genes of liver cancer by networking of multiple data sets.","volume":"16","author":"Deng","year":"2019","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-021-08520-1","article-title":"Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer.","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"1218496","DOI":"10.3389\/fmed.2023.1218496","article-title":"Bioinformatics-based and multiscale convolutional neural network screening of herbal medicines for improving the prognosis of liver cancer: a novel approach.","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R17-20261024","first-page":"445","article-title":"CYP3A4 gene is a novel biomarker for predicting a poor prognosis in hepatocellular carcinoma.","volume":"14","author":"Ashida","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-020-00880-8","article-title":"The application and prospect of CDK4\/6 inhibitors in malignant solid tumors.","volume":"13","author":"Du","year":"2020","journal-title":"J Hematol Oncol"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737159.2021.1987217","article-title":"Predictive biomarkers for systemic therapy of hepatocellular carcinoma.","volume":"21","author":"Moldogazieva","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"e35604","DOI":"10.1097\/MD.0000000000035604","article-title":"Role of TOP2A and CDC6 in liver cancer.","volume":"102","author":"Jia","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12935-021-02439-0","article-title":"Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.","volume":"22","author":"Meng","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"1000847","DOI":"10.3389\/fmolb.2022.1000847","article-title":"Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis.","volume":"9","author":"Gao","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"105491","DOI":"10.1016\/j.fitote.2023.105491","article-title":"New eudesmanolides from Artemisia verlotorum and their potential targets of hepatocellular carcinoma by network pharmacology.","volume":"167","author":"Dong","year":"2023","journal-title":"Fitoterapia"},{"key":"R24-20261024","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.3390\/cancers13225680","article-title":"Cyclin E1 in murine and human liver cancer: a promising target for therapeutic intervention during tumour progression.","volume":"13","author":"Sonntag","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.mce.2015.01.043","article-title":"Interplay of estrogen receptors and FOXA factors in the liver cancer.","volume":"418","author":"Zhao","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11010-020-03927-z","article-title":"miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.","volume":"476","author":"Wang","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"R28-20261024","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.119.116897","article-title":"Ligand-free estrogen receptor \u03b1 (ESR1) as master regulator for the expression of CYP3A4 and other cytochrome P450 enzymes in the human liver.","volume":"96","author":"Wang","year":"2019","journal-title":"Mol Pharmacol"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2019.05.097","article-title":"Degradation of pristine and oxidized single wall carbon nanotubes by CYP3A4.","volume":"515","author":"El-Sayed","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-20261024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12964-020-00539-4","article-title":"Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.","volume":"18","author":"Lu","year":"2020","journal-title":"Cell Commun Signal"},{"key":"R31-20261024","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.3390\/ijms24087131","article-title":"Design, synthesis and biological evaluation of multi-target anti-cancer agent PYR26.","volume":"24","author":"He","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R32-20261024","doi-asserted-by":"crossref","first-page":"12967","DOI":"10.1080\/21655979.2021.2012069","article-title":"Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.","volume":"12","author":"Dong","year":"2021","journal-title":"Bioengineered"},{"key":"R33-20261024","first-page":"4343","article-title":"TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.","volume":"12","author":"Wang","year":"2022","journal-title":"Am J Cancer Res"},{"key":"R34-20261024","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1038\/s41467-022-29960-8","article-title":"Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.","volume":"13","author":"Ng","year":"2022","journal-title":"Nat Commun"},{"key":"R35-20261024","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s13402-021-00617-w","article-title":"Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.","volume":"44","author":"Shen","year":"2021","journal-title":"Cell Oncol (Dordr)"},{"key":"R36-20261024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5114\/aoms.2019.91351","article-title":"MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA).","volume":"16","author":"Zhang","year":"2020","journal-title":"Arch Med Sci"},{"key":"R37-20261024","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41420-023-01620-w","article-title":"LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov"},{"key":"R38-20261024","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.1807155115","article-title":"Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.","volume":"115","author":"Sonntag","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20261024","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2019.03.016","article-title":"Ccne1 overexpression causes chromosome instability in liver cells and liver tumor development in mice.","volume":"157","author":"Aziz","year":"2019","journal-title":"Gastroenterology"},{"key":"R40-20261024","doi-asserted-by":"crossref","first-page":"eabp9435","DOI":"10.1126\/sciadv.abp9435","article-title":"Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases.","volume":"8","author":"Wan","year":"2022","journal-title":"Sci Adv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:00:51Z","timestamp":1792832451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":40,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050231","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2023-12-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}